TGA approves Pfizer booster shots for Aussie adults

The Therapeutic Goods Administration has just approved Pfizer booster shots for Australians aged over 18-years-old.

The provisional approval means that adults may receive a booster at least six months after their second dose of the vaccine.

“This primary series can be of any of the COVID-19 vaccines registered for use in Australia, although data on the use of COMIRNATY as a booster with other COVID-19 vaccines is more limited,” the TGA said in a statement on Wednesday.


“Individuals who have received one dose of COMIRNATY should preferably receive a second dose of COMIRNATY to complete the primary vaccination course and for any additional doses.”

The medical body said further advice on the use of boosters will be provided to the government shortly by the Australian Technical Advisory Group on Immunisation.

“TGA provisionally approved the booster dose following careful evaluation of the available data supporting safety and efficacy,” they said.

“The TGA’s decision was also informed by expert advice from the Advisory Committee on Vaccines, an independent committee with scientific, clinical and consumer representation.”

It’s understood the boosters will be distributed as early as November, with frontline workers to be the first in line.

“They’ll immediately be brought into play once we’ve got the ATAGI advice and then we would hope to see Moderna soon after that,” Vaccine Co-ordinator Lieutenant General John Frewen said earlier this week.

“We think what will happen is that as people become eligible from six months, they’ll just be able to go and grab a booster shot.”

Prime Minister Scott Morrison said National Cabinet will discuss the shots next week.

“We will be approving those plans over the course of the next week, the national cabinets meeting in a week or so, but before that our cabinet is considering some further issues today as the booster program is coming together.

“We will be starting particularly with those in aged care facilities like we did with the vaccine program”.